Incorporating Incretin-Based Therapies into Clinical Practice for Patients with Type 2 Diabetes

BACKGROUND: Effective, evidence-based management of type 2 diabetes (T2D) requires the integration of the best available evidence with clinical experience and patient preferences. METHODS: Studies published from 2000 to 2012 evaluating glucagon-like peptide-1 receptor agonists (GLP-1RAs) or dipeptid...

Descripción completa

Detalles Bibliográficos
Autor principal: Tibaldi, Joseph M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961600/
https://www.ncbi.nlm.nih.gov/pubmed/24535623
http://dx.doi.org/10.1007/s12325-014-0100-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961600/
https://www.ncbi.nlm.nih.gov/pubmed/24535623
http://dx.doi.org/10.1007/s12325-014-0100-5

Ejemplares similares